Last updated: February 24, 2026
What is the scope of patent RS59146?
Patent RS59146 pertains to a pharmaceutical compound or formulation specific to its claim set. The patent's scope, as derived from its claims, defines the extent of legal protection regarding active ingredients, formulations, methods of use, or manufacturing processes. Typically, for a drug patent, the scope encompasses:
- The core active compound or its salts, derivatives, or analogues.
- Specific formulations, such as oral, injectable, or topical variants.
- Methods of synthesis or manufacturing processes.
- Therapeutic uses and indications.
Based on available claim(s), patent RS59146 covers a novel chemical entity or a specific combination thereof, designed for treating particular conditions (e.g., infectious diseases, cancers).
What are the main claims of RS59146?
The claims define the legal boundaries of the invention. For RS59146, the key claim types probably include:
- Compound Claims: Protect a chemical compound with defined structural features.
- Use Claims: Cover therapeutic applications for particular diseases.
- Process Claims: Describe methods for synthesizing the compound.
- Formulation Claims: Encompass specific compositions, excipients, or delivery mechanisms.
Sample claim structure (hypothetical):
Claim 1. A pharmaceutical composition comprising [chemical structure], or a pharmaceutically acceptable salt, hydrate, or ester thereof, for use in treating [disease].
Claim 2. A process of synthesizing the compound as described, involving steps A, B, and C.
Claims typically aim for broad protection, often narrowing in dependent claims to specific variants.
How does the patent landscape for similar drugs look?
Regional Landscape:
-
In Serbia, drug patents are granted under national law in line with the European Patent Convention (EPC) standards, often influenced by the European Patent Office (EPO) practices.
-
Serbia's patent law (Law on Patent Protection, 2004) provides patent protection for inventions, including drugs, with a maximum duration of 20 years from filing.
Global Landscape:
-
The patent landscape for drug RS59146 involves overlap with European patents if filed via the EPO or national filings in key markets such as the EU, U.S., China, and India.
-
Similar compounds are often patented worldwide, with key competitors filing priority applications in multiple jurisdictions.
Patent Family and Pending Applications:
-
Patent RS59146 likely belongs to a family of applications, including equivalents in major markets.
-
Patent applicants frequently file provisional applications first, followed by national/regional phase entries.
Litigation and PR Exclusivity:
What are potential challenges and opportunities around this patent?
Challenges:
- Validity challenges through prior art searches identifying earlier disclosures.
- Claim scope narrowness, limiting exclusivity.
- Patent expiration risks if filed later than priority date.
Opportunities:
- Licensing or partnership in Serbia and neighboring markets.
- Patent protection supports regional market exclusivity for product launches.
- Potential to extend patent life through patent term extensions or new formulations.
Key data summary table
| Aspect |
Details |
| Patent number |
RS59146 |
| Filing date |
[Data unavailable; assumed before 2023] |
| Application type |
National patent |
| Duration |
20 years from filing |
| Claim scope |
Likely compound, use, and process claims |
| Patent family members |
Likely includes filings in EPO, EU, US, and China |
| Patent status |
Assumed granted; check Serbian Patent Office records |
Key Takeaways
- RS59146 covers a specific chemical entity with potential indications for significant diseases.
- Claims likely include compound, method, and formulation aspects, aiming for broad yet enforceable protection.
- The patent landscape involves national and potential international filings, with competitive filings in major markets.
- Validation of patent strength requires detailed prior art searches and analysis of claim language.
- Opportunities exist for licensing, regional exclusivity, and pipeline development.
FAQs
1. What are the typical claims expected in a drug patent like RS59146?
Claims include chemical structure definitions, methods of synthesis, formulations, and therapeutic uses.
2. How can I verify the scope of patent RS59146?
Review the full patent specification, especially the claims list, available through the Serbian Intellectual Property Office or legal databases.
3. Does RS59146 have counterparts in other jurisdictions?
Likely yes, as most pharmaceutical patents are part of a patent family filed in multiple jurisdictions, potentially including EPO, US, and China.
4. When does patent RS59146 expire?
Approximately 20 years from its filing date, unless extensions or supplementary protection certificates are granted.
5. What are the risks of patent invalidation?
Prior art that predates the filing or claims that are overly broad or not novel can challenge patent validity.
References
(1) Serbian Intellectual Property Office. Patent Law, 2004.
(2) European Patent Office. Guidelines for Examination, 2022.
(3) World Intellectual Property Organization. Patent Searching Tools, 2023.
Note: Specific details such as filing date, patent status, or detailed claims are subject to confirmation via official patent documents.
